The short answer
Type 1 diabetes starts years before symptoms. A blood test for islet autoantibodies can find it early. US guidance says screening should be offered to children and adults with a family history of type 1, or other known genetic risk.
Finding it early means less chance of being diagnosed in an emergency, closer monitoring, and the option of teplizumab, a medicine that delays the need for insulin by about three years on average. In the UK, screening is mainly through research studies.
Here’s how it works, what a result means, and how to decide.
How can type 1 be found before symptoms?
Type 1 diabetes is the immune system attacking the insulin-making cells in the pancreas. That attack leaves a trace in the blood: antibodies against those cells, called islet autoantibodies.
They often appear months or years before blood sugar rises. US guidance now describes type 1 in three stages.
| Stage | What’s happening | Symptoms |
|---|---|---|
| 1 | Two or more autoantibodies. Blood sugar normal | None |
| 2 | Autoantibodies, and blood sugar starting to rise but below diabetes levels | None |
| 3 | Diabetes. Insulin needed | Thirst, peeing a lot, weight loss, tiredness |
What does a positive result mean?
It depends how many antibodies, and what the sugar is doing.
- Stage 1: about 44% develop symptoms within 5 years.
- Stage 2: about 60% within 2 years, and about 75% within 5.
- Children with two or more antibodies: in large studies, nearly 70% developed type 1 within 10 years and 84% within 15.
- One antibody only: lower risk. Around 14 to 15% over 10 years in children. The test is repeated to see if more appear.
So a positive test usually means type 1 is coming. It doesn’t tell you when.
Who should be screened?
US guidance says autoantibody screening should be offered to people with a family history of type 1, or other known high genetic risk.
But here’s the catch. About 90% of people who get type 1 have no relative with it. That’s why researchers are testing screening for all children.
In the UK, screening is offered through research studies, according to Diabetes UK:
- ELSA: children aged 3 to 13
- T1DRA: adults aged 18 to 70
People who test positive can join the UK Islet Autoantibody Registry for free follow-up tests and specialist nurse support.
Why screen at all?
Fewer emergency diagnoses. Between 25% and 50% of people with type 1 are diagnosed only when they’re already in DKA, a life-threatening emergency. Families who know to watch can catch it earlier.
Time to prepare. Learning about insulin before you need it is easier than learning in a hospital bed.
Treatment that delays it. Teplizumab can push back the need for insulin. See below.
Research. Children in stage 1 or 2 can join prevention trials.
Are there downsides?
Yes, and they’re worth weighing.
- Worry. A positive result can hang over a family for years.
- Repeated blood tests. Monitoring runs every 6 months to every few years, depending on age and result.
- Uncertainty. A single antibody may never lead anywhere.
A negative test also isn’t a lifetime guarantee, especially in young children.
What is teplizumab?
An immune treatment given as a drip once a day for 14 days. It calms the immune attack on the beta cells.
The UK regulator licensed it in August 2025 for people aged 8 and over with early, symptom-free type 1. It delayed the insulin-treated stage by about three years on average. Results vary.
Diabetes UK reports that NICE approved it for the NHS in England and Wales in 2026, but it isn’t available yet while services are set up. In the US it’s approved from age 1.
What should every parent know anyway?
Screened or not, know the signs of type 1: needing the toilet a lot, being very thirsty, being very tired, and losing weight. If you see them, ask for a same-day finger-prick blood sugar test. Don’t wait.
More in type 1 diabetes: symptoms, diagnosis and starting insulin and the warning signs of DKA.
The bottom line
If type 1 runs in your family, screening is worth asking about. It turns a frightening emergency into something you can see coming, and opens the door to treatment that buys time.
If it doesn’t run in the family, know the four signs. That’s the screening every child gets.
The overview is in our type 1 diabetes guide.
Sources
- American Diabetes Association. Standards of Care in Diabetes 2026, section 2: Diagnosis and classification of diabetes.
- Diabetes UK. Teplizumab.
General public information, not personalised treatment advice. Children, pregnancy and complex health conditions need individual specialist advice. Don’t start, stop or change a medicine without speaking to your own healthcare team.